ATIR: Pivotal trial start

In early 2009, Kiadis will begin an international, pivotal trial (CR-AIR-004) in 60 patients with acute lymphoblastic leukemia (ALL), acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS...